NVTA
Invitae Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Market Cap: 130 Million
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: https://www.invitae.com
Shares Outstanding: 286 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 3.1350018237527317
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Ethical Flags
Longest drawdown: 1025 trading days
From: 2015-02-18 To: 2019-03-08
Lowest Point:
X4 Pharma to fund no-cost genetic testing for rare immune deficiency disorder; shares up 3%
via: SeekingAlpha at 2019-06-12 06:35:20:000
Aimed at providing greater access to faster and earlier diagnosis for people who may have a genetic mutation linked to WHIM syndrome and severe congenital neutropenia, X4 Pharmaceuticals ( XFOR +2.6% ) will partner with Invitae ( NVTA -1.4% ) to offer free-of-charge genetic testin… read more...
X4 Pharma to fund no-cost genetic testing for rare immune deficiency disorder; shares up 3%
via: SeekingAlpha at 2019-06-12 06:35:20:000
Aimed at providing greater access to faster and earlier diagnosis for people who may have a genetic mutation linked to WHIM syndrome and severe congenital neutropenia, X4 Pharmaceuticals ( XFOR +2.6% ) will partner with Invitae ( NVTA -1.4% ) to offer free-of-charge genetic testin… read more...
X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease
via: Business Wire at 2019-06-12 04:30:00:000
Genetic testing to enable improved patient diagnoses and provide valuable disease-specific genetic insights for X4 clinical development of novel therapies X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeu… read more...
X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease
via: Business Wire at 2019-06-12 04:30:00:000
Genetic testing to enable improved patient diagnoses and provide valuable disease-specific genetic insights for X4 clinical development of novel therapies X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeu… read more...
Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders
via: PR Newswire at 2019-06-12 03:30:00:000
SAN FRANCISCO , June 12,2019 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of ID YOUR IRD, an initiative with Spark Therapeutics to offer genetic testing at no charge to patients suspected by their healthcare providers of havi… read more...
Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders
via: PR Newswire at 2019-06-12 03:30:00:000
SAN FRANCISCO , June 12,2019 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of ID YOUR IRD, an initiative with Spark Therapeutics to offer genetic testing at no charge to patients suspected by their healthcare providers of havi… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|